Miriam Merad named dean for Translational Research and Therapeutic Innovation at Mt. Sinai

Aditya Bardia to lead breast cancer program and translational research integration at UCLA Health

Aditya Bardia, a breast medical oncologist and physician scientist who specializes in developing novel targeted and personalized therapies, joined the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center, where he will assume several leadership roles across the institution.

December 15, 2023

Vol.49 No.46

In Brief

Sarki Abdulkadir, Patricia Robinson named to senior leadership positions at Northwestern

Sarki A. AbdulkadirPatricia RobinsonSarki A. Abdulkadir and Patricia Robinson have been named to senior leadership positions at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, effective Nov. 1.

December 01, 2023

Vol.49 No.44

In Brief

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

The Department of Immunology and Immunotherapy and the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai has received a $5 million grant from NCI to establish a center dedicated to the discovery and development of cutting-edge targets for cancer therapy.

November 17, 2023

Vol.49 No.43

Clinical Roundup

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed “prognostic modules,” that significantly influence the progression of 32 different types of cancer.

November 17, 2023

Vol.49 No.43

In Brief

Alan Bryce named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen

Alan H. Bryce was named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope.

November 10, 2023

Vol.49 No.42

Clinical Roundup

PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find

Mount Sinai researchers have discovered a link between certain per- and polyfluoroalkyl substances and an increased risk for thyroid cancer, according to a study published in eBioMedicine.

October 27, 2023

Vol.49 No.40

Miriam Merad named dean for Translational Research and Therapeutic Innovation at Mt. Sinai

YOU MAY BE INTERESTED IN

Aditya Bardia to lead breast cancer program and translational research integration at UCLA Health

Sarki Abdulkadir, Patricia Robinson named to senior leadership positions at Northwestern

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

Alan Bryce named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen

PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find

Renew today!

Subscriber content

Login